Clinical Trial

Myotubular and Centronuclear Myopathy Patient Registry

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2025 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
The Myotubular and Centronuclear Myopathy Patient Registry (also referred to as the 'MTM and CNM Registry') is an international, patient-reported database specific to these conditions. More details and online registration are available at www.mtmcnmregistry.org.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2019-08-19; most recent amendment 2025-04-07.
Trial Details
NCT Number NCT04064307
Lead Sponsor Newcastle-upon-Tyne Hospitals NHS Trust
Collaborators: Myotubular Trust, Muscular Dystrophy UK, Astellas Gene Therapies, Astellas Pharma Inc
Conditions Myotubular Myopathy, Myotubular Myopathy 1, Myotubular (Centronuclear) Myopathy, Centronuclear Myopathy, Centronuclear Myopathy, X-Linked, X-linked Myotubular Myopathy
Enrollment 500 participants
Start Date 2013-03-26
Primary Completion 2025-05 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2025-04-09